Long Non-coding RNAs: At the Heart of Cardiac Dysfunction?

Bennett, 2017, Pharmacology of Antisense drugs., Annu. Rev. Pharmacol. Toxicol., 57, 81, 10.1146/annurev-pharmtox-010716-104846

Burdick, 2014, Sequence motifs associated with hepatotoxicity of locked nucleic acid-modified antisense oligonucleotides., Nucleic Acids Res., 42, 4882, 10.1093/nar/gku142

Chen, 2018, Valsartan regulates TGF-β/Smads and TGF-β/p38 pathways through lncRNA CHRF to improve doxorubicin-induced heart failure., Arch. Pharm. Res., 41, 101, 10.1007/s12272-017-0980-4

De Gonzalo-Calvo, 2016, Circulating long-non coding RNAs as biomarkers of left ventricular diastolic function and remodelling in patients with well-controlled type 2 diabetes., Sci. Rep., 6, 1, 10.1038/srep37354

Devaux, 2015, Long noncoding RNAs in cardiac development and ageing., Nat. Rev. Cardiol., 12, 415, 10.1038/nrcardio.2015.55

Gast, 2018, Immune system-mediated atherosclerosis caused by deficiency of long non-coding RNA MALAT1 in ApoE-/-mice., Cardiovasc. Res., 10.1093/cvr/cvy202

Geary, 2015, Clinical and Preclinical pharmacokinetics and pharmacodynamics of mipomersen (Kynamro®): a Second-generation antisense oligonucleotide inhibitor of apolipoprotein B., Clin. Pharmacokinet., 54, 133, 10.1007/s40262-014-0224-4

Grote, 2015, Long noncoding RNAs in organogenesis: making the difference., Trends Genet., 31, 329, 10.1016/j.tig.2015.02.002

Grote, 2013, The tissue-specific lncrna fendrr is an essential regulator of heart and body wall development in the mouse., Dev. Cell, 24, 206, 10.1016/j.devcel.2012.12.012

Gutschner, 2017, From biomarkers to therapeutic targets – The promises and perils of long non-coding RNAs in cancer., Cancer Metastasis Rev., 37, 83, 10.1007/s10555-017-9718-5

Han, 2014, A long noncoding RNA protects the heart from pathological hypertrophy., Nature, 514, 102, 10.1038/nature13596

Huang, 2018, Long noncoding RNA MALAT1 mediates cardiac fibrosis in experimental postinfarct myocardium mice model., J. Cell. Physiol., 1, 1, 10.1002/jcp.27117

Ishii, 2006, Identification of a novel non-coding RNA, MIAT, that confers risk of myocardial infarction., J. Hum. Genet., 51, 1087, 10.1007/s10038-006-0070-9

Klattenhoff, 2013, Braveheart, a long noncoding RNA required for cardiovascular lineage commitment., Cell, 152, 570, 10.1016/j.cell.2013.01.003

Krenz, 2004, Impact of beta-myosin heavy chain expression on cardiac function during stress., J. Am. Coll. Cardiol., 44, 2390, 10.1016/j.jacc.2004.09.044

Kumarswamy, 2014, Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure., Circ. Res., 114, 1569, 10.1161/CIRCRESAHA.114.303915

Lai, 2017, HOTAIR functions as a competing endogenous RNA to regulate PTEN expression by inhibiting miR-19 in cardiac hypertrophy., Mol. Cell. Biochem., 432, 179, 10.1007/s11010-017-3008-y

Lennox, 2016, Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotides., Nucleic Acids Res., 44, 863, 10.1093/nar/gkv1206

Li, , Obestatin attenuated doxorubicin-induced cardiomyopathy via enhancing long noncoding Mhrt RNA expression., Biomed. Pharmacother., 81, 474, 10.1016/j.biopha.2016.04.017

Li, 2015, Plasma long noncoding RNA protected by exosomes as a potential stable biomarker for gastric cancer., Tumor Biol., 36, 2007, 10.1007/s13277-014-2807-y

Li, , LncRNA H19/miR-675 axis regulates cardiomyocyte apoptosis by targeting VDAC1 in diabetic cardiomyopathy., Sci. Rep., 6, 1, 10.1038/srep36340

Li, 2017, Inhibition of the lncRNA Mirt1 attenuates acute myocardial infarction by suppressing NF-κB activation., Cell. Physiol. Biochem., 42, 1153, 10.1159/000478870

Li, 2018, LncRNA myocardial infarction-associated transcript (MIAT) contributed to cardiac hypertrophy by regulating TLR4 via miR-93., Eur. J. Pharmacol., 818, 508, 10.1016/j.ejphar.2017.11.031

Liu, 2016, The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy., Cardiovasc. Res., 111, 56, 10.1093/cvr/cvw078

Long, 2018, Long noncoding RNA FTX regulates cardiomyocyte apoptosis by targeting miR-29b-1-5p and Bcl2l2., Biochem. Biophys. Res. Commun., 495, 312, 10.1016/j.bbrc.2017.11.030

Lucas, 2018, RNA therapeutics in cardiovascular disease., Circ. Res., 123, 205, 10.1161/CIRCRESAHA.117.311311

Martignano, 2017, Urinary RNA-based biomarkers for prostate cancer detection., Clin. Chim. Acta, 473, 96, 10.1016/j.cca.2017.08.009

Mendell, 2016, Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy., Ann. Neurol., 79, 257, 10.1002/ana.24555

Mendell, 2013, Eteplirsen for the treatment of Duchenne muscular dystrophy., Ann. Neurol., 37, e109, 10.1002/ana.23982

Micheletti, 2017, The long noncoding RNA Wisper controls cardiac fibrosis and remodeling., Sci. Transl. Med., 9, 10.1126/scitranslmed.aai9118

Miyata, 2000, 86, 386, 10.1161/01.RES.86.4.386

Noh, 2018, Cytoplasmic functions of long noncoding RNAs., Wiley Interdiscip. Rev. RNA, 9, 10.1002/wrna.1471

Pan, 2017, Exosomes-mediated transfer of long noncoding RNA ZFAS1 promotes gastric cancer progression., J. Cancer Res. Clin. Oncol., 143, 991, 10.1007/s00432-017-2361-2

Piccoli, 2017, Inhibition of the cardiac fibroblast-enriched lncRNA Meg3 prevents cardiac fibrosis and diastolic dysfunction., Circ. Res., 121, 575, 10.1161/CIRCRESAHA.117.310624

Qu, 2017, MIAT is a pro-fibrotic long non-coding RNA governing cardiac fibrosis in post-infarct myocardium., Sci. Rep., 7, 1, 10.1038/srep42657

Quiat, 2013, MicroRNAs in cardiovascular disease: from pathogenesis to prevention and treatment., J. Clin. Invest., 123, 11, 10.1172/JCI62876.mature

Rader, 2014, Lomitapide and mipomersen: two first-in-class drugs for reducing low-density lipoprotein cholesterol in patients with homozygous familial hypercholesterolemia., Circulation, 129, 1022, 10.1161/CIRCULATIONAHA.113.001292

Rahimi, 2018, Association of ANRIL expression with coronary artery disease in type 2 diabetic patients., Cell J., 20, 41, 10.22074/cellj.2018.4821

Raveh, 2015, The H19 long non-coding RNA in cancer initiation, progression and metastasis – A proposed unifying theory., Mol. Cancer, 14, 1, 10.1186/s12943-015-0458-2

Santos, 2015, Mipomersen, an Antisense oligonucleotide to apolipoprotein B-100, reduces lipoprotein(a) in Various populations with hypercholesterolemia: results of 4 phase III trials., Arterioscler. Thromb. Vasc. Biol., 35, 689, 10.1161/ATVBAHA.114.304549

Smith, 2019, Therapeutic oligonucleotides: state of the art., Annu. Rev. Pharmacol. Toxicol., 59, 10.1146/annurev-pharmtox-010818-021050

Sun, 2017, Nuclear long noncoding RNAs: key regulators of gene expression., Trends Genet., 34, 142, 10.1016/j.tig.2017.11.005

Swayze, 2007, Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animals., Nucleic Acids Res., 35, 687, 10.1093/nar/gkl1071

Terracciano, 2017, Urinary long noncoding RNAs in nonmuscle-invasive bladder cancer: new architects in cancer prognostic biomarkers., Transl. Res., 184, 108, 10.1016/j.trsl.2017.03.005

Thum, 2014, Noncoding RNAs and myocardial fibrosis., Nat. Rev. Cardiol., 11, 655, 10.1038/nrcardio.2014.125

Van Den Borne, 2010, Myocardial remodeling after infarction: the role of myofibroblasts., Nat. Rev. Cardiol., 7, 30, 10.1038/nrcardio.2009.199

Vausort, 2014, Long noncoding RNAs in patients with acute myocardial infarction., Circ. Res., 115, 668, 10.1161/CIRCRESAHA.115.303836

Viereck, 2016, Long noncoding RNA Chast promotes cardiac remodeling., Sci. Transl. Med., 8, a22, 10.1126/scitranslmed.aaf1475

Viereck, 2017, Circulating noncoding RNAs as biomarkers of cardiovascular disease and injury., Circ. Res., 120, 381, 10.1161/CIRCRESAHA.116.308434

Wang, 2017, Prognostic Value of plasma long noncoding RNA ANRIL for in-stent restenosis., Med. Sci. Monit., 23, 4733, 10.12659/MSM.904352

Wang, 2015, MicroRNA-103/107 regulate programmed necrosis and myocardial ischemia/reperfusion injury through targeting FADD., Circ. Res., 117, 352, 10.1161/CIRCRESAHA.117.305781

Wang, , The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489., Circ. Res., 114, 1377, 10.1161/CIRCRESAHA.114.302476

Wang, , CARL lncRNA inhibits anoxia-induced mitochondrial fission and apoptosis in cardiomyocytes by impairing miR-539-dependent PHB2 downregulation., Nat. Commun., 5, 10.1038/ncomms4596

Wang, , MDRL lncRNA Regulates the processing of miR-484 primary transcript by targeting miR-361., PLoS Genet., 10, 10.1371/journal.pgen.1004467

Wang, 2016, The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy., Nat. Med., 22, 1131, 10.1038/nm.4179

2017, Fact Sheet Cardiovascular diseases (CVDs)

Wu, 2018, Long noncoding RNA Meg3 regulates cardiomyocyte apoptosis in myocardial infarction., Gene Ther., 25, 511, 10.1038/s41434-018-0045-4

Xuan, 2017, Circulating long non-coding RNAs NRON and MHRT as novel predictive biomarkers of heart failure., J. Cell. Mol. Med., 21, 1803, 10.1111/jcmm.13101

Yeowell, 2009, TIA nuclear proteins regulate the alternate splicing of lysyl hydroxylase 2., J. Invest. Dermatol., 129, 1402, 10.1038/jid.2008.386

Zhang, 2018, Exosome-mediated delivery of MALAT1 induces cell proliferation in breast cancer., Onco. Targets. Ther., 11, 291, 10.2147/OTT.S155134

Zhang, 2017, Increased plasma levels of lncRNA H19 and LIPCAR are associated with increased risk of coronary artery disease in a Chinese population., Sci. Rep., 7, 10.1038/s41598-017-07611-z

Zhou, 2018, Long non-coding RNA H19 protects acute myocardial infarction through activating autophagy in mice., Eur. Rev. Med. Pharmacol. Sci., 22, 5647

Zhou, 2015, Identification of the long non-coding RNA H19 in plasma as a novel biomarker for diagnosis of gastric cancer., Sci. Rep., 5, 1, 10.1038/srep11516

Zhou, 2017, lncRNA MIAT functions as a competing endogenous RNA to upregulate DAPK2 by sponging miR-22-3p in diabetic cardiomyopathy., Cell Death Dis., 8, 10.1038/cddis.2017.321

Zhu, 2016, LncRNA MIAT enhances cardiac hypertrophy partly through sponging miR-150., Eur. Rev. Med. Pharmacol. Sci., 20, 3653